Biotech Investor Makes 2nd Push For $1.4M Deal Approval
A proposed class of investors in biotechnology company Longeveron Inc. has renewed its bid for an initial green light for a nearly $1.4 million settlement deal with the company after a...To view the full article, register now.
Already a subscriber? Click here to view full article